Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog – Page 3690

Do you like our content? Please support PRO Robots on Patreon.
—
https://www.patreon.com/PRORobots.
—
Your contributions will help us to create better content and to improve our service for you and our PRO Robots community. Every dollar counts and will help us keep working for you.
Thank you for your support!

All about AI: https://youtu.be/Ic8yVrm58lI

—
👉For business inquiries: [email protected].
✅ Instagram: https://www.instagram.com/pro_robots.
—
Will artificial intelligence destroy humanity? Will GPT-5 be the first artificial general intelligence? Why are neural network experts calling on missile strikes to destroy the AI development centers? That and review of new robot superpowers and the ProMat 2023 robot show is in one video! Watch till the end, it’s gonna be interesting!

00:38 — Will GPT-5 destroy humanity?

Continue reading “GPT-5: A New Era of Artificial Intelligence or the Beginning of the End of Mankind? | Pro Robots” | >

Noisy intermediate-scale quantum algorithms, which run on noisy quantum computers, should be carefully designed to boost the output state fidelity. While several compilation approaches have been proposed to minimize circuit errors, they often omit the detailed circuit structure information that does not affect the circuit depth or the gate count. In the presence of spatial […]…

Read more | >

Scientists at the University of Cambridge have designed a robotic hand that can grasp and hold objects using only the movement of its wrist.

The 3D printed model was implanted with sensors that enabled it to “sense” what it was touching and more than 1,200 tests were carried out, using objects including a peach, computer mouse and bubble wrap.

Please subscribe here: http://bit.ly/1rbfUog.

#Robots #BBCNews

Continue reading “Scientists create robotic hand able to hold objects — BBC News” | >

Four small rooms, a gym and a lot of red sand—NASA unveiled on Tuesday its new Mars-simulation habitat, in which volunteers will live for a year at a time to test what life will be like on future missions to Earth’s neighbor.

The facility, created for three planned experiments called the Crew Health and Performance Exploration Analog (CHAPEA), is located at the US space agency’s massive research base in Houston, Texas.

Four volunteers will begin the first trial this summer, during which NASA plans to monitor their physical and to better understand humans’ fortitude for such a long isolation.

Read more | >

Pictured: Illustration of CRISPR-Cas9 editing DNA / iStock, Artur Plawgo

Currently, there are no gene editing–based treatments on the market, but the technology continues its march toward potential FDA approval, with several products in mid-and late-stage trials. As these programs mature, 2023 could be a pivotal year for companies in the space. Here are some highlights to look forward to as the year progresses.

CRISPR Therapeutics/Vertex Pharmaceuticals.

Read more | >

In the last decade, we have witnessed biology bring us some incredible products and technologies: from mushroom-based packaging to animal-free hotdogs and mRNA vaccines that helped curb a global pandemic. The power of synthetic biology to transform our world cannot be overstated: this industry is projected to contribute to as much as a third of the global economic output by 2030, or nearly $30 trillion, and could impact almost every area of our lives, from the food we eat to the medicine we put in our bodies.

The leaders of this unstoppable bio revolution – many of whom you can meet at the SynBioBeta conference in Oakland, CA, on May 23–25 – are bringing the future closer every day through their ambitious vision, long-range strategy, and proactive oversight. These ten powerful women are shaping our world as company leaders, biosecurity experts, policymakers, and philanthropists focused on charting a new course to a more sustainable, equitable, clean, and safe future.

As an early pioneer in the high-throughput synthesis and sequencing of DNA, Emily Leproust has dedicated her life to democratizing gene synthesis to catapult the growth of synthetic biology applications from medicine, food, agriculture, and industrial chemicals to DNA data storage. She was one of the co-founders of Twist Bioscience in 2013 and is still leading the expanding company as CEO. To say that Twist’s silicon platform was a game-changer for the industry is an understatement. And it is no surprise that Leproust was recently honored with the BIO Rosalind Franklin Award for her work in the biobased economy and biotech innovation.

Read more | >